Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor
Detection of DNA molecules and possible chemotherapy-induced changes in its structure has been the goal of researchers using rapid, sensitive and inexpensive approaches. Therefore, the aim of this study was to fabricate a new electrochemical DNA biosensor using pencil graphite electrodes modified wi...
Main Authors: | Zimeng Lei, Merim Alwan, Hassan Thoulfikar A. Alamir, Hussein Humedy Chlib Alkaaby, Sinan Subhi Farhan, Sura A. Awadh, Usama S. Altimari, Hawra’a Fadhel Abbas Al-Baghdady, Athmar Ali Kadhim, Maytham T. Qasim, Ali Hussein Adhab, Abuzar Nekuei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.980162/full |
Similar Items
-
Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas
by: Muh-Lii Liang, et al.
Published: (2020-12-01) -
Development of a SPE-LC-MS Method for the Quantitation of Palbociclib and Abemaciclib in Human Plasma
by: Daniela Maria Calucică, et al.
Published: (2022-12-01) -
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story
by: Vittorio Gebbia
Published: (2023-04-01) -
Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy
by: Hiroaki Ogata, et al.
Published: (2024-03-01) -
Efficiency and tolerability of abemaciclib in elderly patients
by: E. I. Kovalenko, et al.
Published: (2020-12-01)